NEW YORK, NY / ACCESSWIRE / April 18, 2016 / The week just gone gave us plenty to talk about in the biotech space, with two significant developments - one in oncology and one in a rare genetic growth disorder called acromegaly. Here's what happened, and how things played out as a result.
This weeks report covers the following companies:
- Clovis Oncology Inc (NASDAQ: CLVS)
- Chiasma Inc (NASDAQ: CHMA)
- Sarepta Therapeutics Inc (NASDAQ: SRPT)
- Collegium Pharmaceutical Inc. (NASDAQ: COLL)
- Progenics Pharmaceuticals (Nasdaq: PGNX)
Click here to continue reading.
SOURCE: Market Exclusive
ReleaseID: 438924
